Follow
Brett Wendling
Title
Cited by
Cited by
Year
The joint demand for cigarettes and marijuana: evidence from the National Household Surveys on Drug Abuse
MC Farrelly, JW Bray, GA Zarkin, BW Wendling
Journal of health economics 20 (1), 51-68, 2001
1642001
The effects of prices and policies on the demand for marijuana: Evidence from the National Household Surveys on Drug Abuse
MC Farrelly, JW Bray, G Zarkin, B Wendling, RL Pacula
National Bureau of Economic Research, 1999
1211999
How vertical integration affects the quantity and cost of care for Medicare beneficiaries
TG Koch, BW Wendling, NE Wilson
Journal of health economics 52, 19-32, 2017
1102017
Healthcare use among US women aged 45 and older: total costs and costs for selected postmenopausal health risks
TJ Hoerger, KE Downs, MC Lakshmanan, RC Lindrooth, LEO Plouffe Jr, ...
Journal of Women's Health & Gender-Based Medicine 8 (8), 1077-1089, 1999
1091999
The role of education in the production of health: An empirical analysis of smoking behavior
S Tenn, DA Herman, B Wendling
Journal of health economics 29 (3), 404-417, 2010
542010
Economics at the FTC: Hospital mergers, authorized generic drugs, and consumer credit markets
J Farrell, DJ Balan, K Brand, BW Wendling
Review of Industrial Organization 39, 271-296, 2011
522011
Entry threats and pricing in the generic drug industry
S Tenn, BW Wendling
Review of Economics and Statistics 96 (2), 214-228, 2014
432014
The effects of physician and hospital integration on medicare beneficiaries' health outcomes
TG Koch, BW Wendling, NE Wilson
Review of Economics and Statistics 103 (4), 725-739, 2021
342021
Physician market structure, patient outcomes, and spending: an examination of Medicare beneficiaries
T Koch, B Wendling, NE Wilson
Health services research 53 (5), 3549-3568, 2018
322018
Economics at the FTC: Drug and PBM mergers and drip pricing
HA Shelanski, J Farrell, D Hanner, CJ Metcalf, MW Sullivan, BW Wendling
Review of Industrial Organization 41, 303-319, 2012
262012
A review of the economic literature on cross-market health care mergers
K Brand, T Rosenbaum
Antitrust LJ 82, 533, 2018
252018
Informing the uninformed: How drug advertising affects check-up visits
D Hosken, B Wendling
International Journal of Industrial Organization 31 (2), 181-194, 2013
192013
Estimating the causal effect of entry on generic drug prices using Hatch–Waxman exclusivity
LM Olson, BW Wendling
Review of Industrial Organization 53, 139-172, 2018
172018
The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period
LM Olson, BW Wendling
Bureau of Economics, Federal Trade Commission, 2013
172013
Economics at the FTC: Physician acquisitions, standard essential patents, and accuracy of credit reporting
JA Carlson, LS Dafny, BA Freeborn, PM Ippolito, BW Wendling
Review of Industrial Organization 43, 303-326, 2013
162013
Estimating the effect of entry on generic drug prices using Hatch-Waxman exclusivity
L Olson, BW Wendling
Federal Trade Commission, Bureau of Economics, Working Paper, 2013
62013
The effect of generic drug competition on generic drug prices during the hatch-waxman 180-day exclusivity period. Washington, DC: Bureau of Economics Federal Trade Commission
LM Olson, BW Wendling
32013
Entry Threats and Pricing in the Generic Drug Industry
B Wendling, S Tenn
Bureau of Economics, Federal Trade Commission, 2010
32010
The Importance of Substitution in Assessing Health Care Provider Mergers
BW Wendling, NE Wilson
The Antitrust Bulletin 59 (3), 515-525, 2014
22014
Physician Market Concentration and Patient Welfare: An Examination of Medicare Beneficiaries
T Koch, BW Wendling, NE Wilson
Health Services Research 53, 3549-3568, 2018
12018
The system can't perform the operation now. Try again later.
Articles 1–20